RT Journal Article
SR Electronic
T1 1048 AB821 is a CD8<sup>+</sup> T cell selective IL-21 with enhanced bioavailability that reduces CD8<sup>+</sup> T cell exhaustion to induce potent antitumor activity
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A1155
OP A1155
DO 10.1136/jitc-2023-SITC2023.1048
VO 11
IS Suppl 1
A1 Greer, Renee
A1 Paul, Arisa
A1 Houser, Jeffrey
A1 Hollingsworth, Audrey
A1 Prior, Wei Wei
A1 Kumar, Manu
A1 Lan, Ruth
A1 Yeung, Yik Andy
A1 Djuretic, Ivana
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A1155.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.